21 games in two years: The true cost of the 'NBA discount ticket' to Europe

Vlatko Čančar will be sidelined for several months following meniscus surgery. The story would be unremarkable if not for one number: the Slovenian forward has played just 21 games since October 2026. This is not a young player finding his footing. This is a six-year NBA veteran, 2.03 m tall, in his prime — and slowly disappearing from the professional basketball map. San Pablo Burgos signed Čančar this summer as a free agent. The Spanish EuroCup club hoped for height and NBA experience. Instead, they received a surgery and months of waiting. This is the second consecutive time a European club has signed Čančar and received nearly nothing. Before this, Armani Milan — Italy's top club in EuroLeague — signed him in 2026. Milan got exactly two games before he went down. European clubs operate differently from the NBA. No hard cap, no complex luxury tax — but that doesn't mean their decisions carry less risk. With smaller rosters and narrower registration windows, losing a foreign player for months hurts more than an equivalent NBA team would. The most notable pattern in Čančar's injury record is location. Achilles in 2026. Right knee in 2026. Now right knee meniscus. Three surgeries in the same body region — knee and lower leg — within three years. This is what sports physicians call a "cumulative load injury pattern": injuries stacking on the same structure, creating a pathological cycle that medicine cannot fully reverse. An ACL tear in 2026, now meniscus damage. In sports physiology, post-ACL meniscus injuries carry two risks: first, the knee already compromised by the old ligament overloads the cartilage cushioning; second, ACL recovery alters movement mechanics, increasing pressure on the meniscus. This is not speculation — this is basic sports injury biology. Čančar's career trajectory tells a clear story of regression. Denver Nuggets kept him for six years — long enough to confirm NBA-level ability. But after leaving Denver in 2026, he couldn't hold a EuroLeague spot (Milan), and has now dropped to EuroCup (Burgos). Each step down means smaller contracts, less leverage, and mounting pressure from age and medical history. The comparison to Keenan Evans is what the original article made. Evans is an American player at Žalgiris Kaunas, suffered three serious injuries in three seasons, and is now loaned down to London Lions. Both are high-quality foreigners destroyed by durability. Both illustrate a structural segment in European basketball: players with high skill ceilings but unable to maintain enough games to prove their value. What makes European clubs repeat the same mistake? The answer lies in "buying the dip" psychology. A six-year NBA veteran, 2.03 m tall, positionally versatile — that profile is significantly cheaper when tagged "injury-prone." Clubs bet that potential value remains, that he can return to peak level, that they will be the last to see it. But with Čančar, every bet loses. His playing style fits the modern "stretch-four" model: tall, mobile, three-point shooting, switchable defense. But no one can confirm this on the court because he never gets enough game time to build rhythm. Without rhythm, there's no system flow. Without system, there's no measurable tactical contribution. The 21-games-in-two-years figure — averaging less than one game per month — shows Čančar is approaching the boundary of what's considered a reliable professional. For Burgos, he is a roster spot that no one knows when it will actually be filled. Čančar's story doesn't end here. Slovenian national team — his country — will need him for upcoming FIBA windows. A rebuilding team with Luka Dončić at center needs every support it can get. But if Čančar can't maintain fitness at club level, how can he guarantee it internationally? EuroCup season is approaching. Burgos will have to fill the gap without any foreign player contribution. In European basketball, each foreign player is a tactical flexibility point. Lose that point, and they must rotate with what they have — and in their hands, a heavier medical record than ever.